Ligand Pharma (NASDAQ: LGND) partner TG Therapeutics, Inc. (NASDAQ: TGTX) announced the first presentation of preclinical data demonstrating single agent ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE